Unoprostone

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
220pxpx }}
Unoprostone
Systematic (IUPAC) name
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)
cyclopentyl]hept-5-enoic acid
Identifiers
CAS number 120373-36-6
120373-24-2 (isopropyl)
ATC code S01EE02
PubChem 5311236
Chemical data
Formula C22H38O5 
Mol. mass 382.534 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes Topical (eye drops)

WikiDoc Resources for

Unoprostone

Articles

Most recent articles on Unoprostone

Most cited articles on Unoprostone

Review articles on Unoprostone

Articles on Unoprostone in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Unoprostone

Images of Unoprostone

Photos of Unoprostone

Podcasts & MP3s on Unoprostone

Videos on Unoprostone

Evidence Based Medicine

Cochrane Collaboration on Unoprostone

Bandolier on Unoprostone

TRIP on Unoprostone

Clinical Trials

Ongoing Trials on Unoprostone at Clinical Trials.gov

Trial results on Unoprostone

Clinical Trials on Unoprostone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Unoprostone

NICE Guidance on Unoprostone

NHS PRODIGY Guidance

FDA on Unoprostone

CDC on Unoprostone

Books

Books on Unoprostone

News

Unoprostone in the news

Be alerted to news on Unoprostone

News trends on Unoprostone

Commentary

Blogs on Unoprostone

Definitions

Definitions of Unoprostone

Patient Resources / Community

Patient resources on Unoprostone

Discussion groups on Unoprostone

Patient Handouts on Unoprostone

Directions to Hospitals Treating Unoprostone

Risk calculators and risk factors for Unoprostone

Healthcare Provider Resources

Symptoms of Unoprostone

Causes & Risk Factors for Unoprostone

Diagnostic studies for Unoprostone

Treatment of Unoprostone

Continuing Medical Education (CME)

CME Programs on Unoprostone

International

Unoprostone en Espanol

Unoprostone en Francais

Businness

Unoprostone in the Marketplace

Patents on Unoprostone

Experimental / Informatics

List of terms related to Unoprostone

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Unoprostone (INN) is a prostaglandin analogue. Its isopropyl ester, unoprostone isopropyl, is marketed under the trade name Rescula for the management of open-angle glaucoma and ocular hypertension.

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools